Atlas Trials

The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population.

Clinical trial NCT05033158 · COMPLETED

Trial details

NCT number
NCT05033158
Sponsor
University Hospital, Antwerp
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cancer
Start date
2021-04-01
Primary completion
2022-12-31
Enrollment
402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.